07 Jan 2001

AscoTop® 2,5 (AscoTop® 2,5 mg Filmtabletten) - Deutschland

Updated: 07 Jan 2001

AscoTop® 2,5 mg; -Schmelztabletten

Akutbehandl. von Migränekopfschmerzen mit od. ohne Aura.

AscoTop® 2,5 Description, Presentation and Dosage

AscoTop® 2,5 Description

AscoTop® 2,5 Drug Class Description

Einzelstoffe

AscoTop® 2,5 Drug Description

1 Filmtbl. enth.: Zolmitriptan 2,5 mg.

AscoTop® 2,5 Generic Name

AscoTop® 2,5 mg Filmtabletten

AscoTop® 2,5 Presentation

AscoTop® 2,5 Presentation

AscoTop® 2,5 mg; -Schmelztabletten

AscoTop® 2,5 Manufacturer

AstraZeneca/Promed

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

AscoTop® 2,5 Dosage

AscoTop® 2,5 Adult Dosage

Lactose, mikrokristalline Cellulose, Natriumcarboxymethylstärke (Typ A), Magnesiumstearat, Hypromellose, Macrogol 400, Macrogol 8000, Eisenoxidhydrat gelb (E 172), Titandioxid (E 171). Natriumhydrogencarbonat.

AscoTop® 2,5 Child Dosage


AscoTop® 2,5 mg Schmelz- tabletten
Zus.: 1 Schmelztbl. enth.: Zolmitriptan 2,5 mg.
Weit. Bestandteile: Aspartam, Citronensäure, hochdisperses Siliciumdioxid, Crospovidon, Magnesiumstearat, D-Mannitol, Mikrokristalline Cellulose, Orangenaroma SN027512,

AscoTop® 2,5 Precautions, Reactions and Contraindications

AscoTop® 2,5 Special Precautions

AscoTop® 2,5 Special Precautions

Mittelschwere, schwere od. unzureichend eingest. leichte Hypertonie. Myokardinfarkt, koronare Herzkrankheit, Koronarspasmen (Prinzmetal-Angina), arterielle Verschlußkrankheit, Schlaganfall od. transistorische ischämische Attacken in der Anamnese. Symptome einer koronaren Herzkrankheit. Gleichz. Verabreichung von Ergotamin, Ergotaminderivaten (einschl. Methysergid), Sumatriptan, Naratriptan u. and. 5HT1B/1D-Agonisten, Kreatinin-Clearance

Related Drugs - Neurological Disorders

Back to top